Lacticaseibacillus paracasei DG enhances the lactoferrin anti-SARS-CoV-2 response in Caco-2 cells
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the ongoing global pandemic of coronavirus disease 2019 (COVID-19), which primarily manifests with respiratory distress and may also lead to symptoms associated with the gastrointestinal tract. Probiotics are living mi...
Main Authors: | Claudio Salaris, Melania Scarpa, Marina Elli, Alice Bertolini, Simone Guglielmetti, Fabrizio Pregliasco, Paola Brun, Ignazio Castagliuolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19490976.2021.1961970 |
Similar Items
-
Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro
by: Claudio Salaris, et al.
Published: (2021-01-01) -
Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense
by: Piera Valenti, et al.
Published: (2018-03-01) -
The Impact of Lactoferrin on the Growth of Intestinal Inhabitant Bacteria
by: Alan Vega-Bautista, et al.
Published: (2019-09-01) -
Bovine Lactoferrin and Lactoferrin-Derived Peptides Inhibit the Growth of Vibrio cholerae and Other Vibrio species
by: Erika Acosta-Smith, et al.
Published: (2018-01-01) -
Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
by: Elena Campione, et al.
Published: (2021-06-01)